Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group A, C Polysaccharide Meningitis”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Post-approval studies (Phase 4)Study completedNCT02864927
What this trial is testing

Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,311
Post-approval studies (Phase 4)Study completedNCT01270503
What this trial is testing

Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 538
Not applicableStudy completedNCT02699840
What this trial is testing

Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT00700713
What this trial is testing

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 181
Large-scale testing (Phase 3)Study completedNCT00617760
What this trial is testing

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Who this might be right for
Neisseria Meningitidis (Bacterial Meningitis)Invasive Pneumococcal Disease (IPD)
Pfizer 330
Not applicableStudy completedNCT00728260
What this trial is testing

36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 1,421
Large-scale testing (Phase 3)Study completedNCT00483574
What this trial is testing

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,378
Post-approval studies (Phase 4)Study completedNCT02591290
What this trial is testing

Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 60
Large-scale testing (Phase 3)Study completedNCT01890759
What this trial is testing

Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 300
Post-approval studies (Phase 4)Study completedNCT01659996
What this trial is testing

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Who this might be right for
MeningitisMeningococcal InfectionDiphtheria+3 more
Sanofi Pasteur, a Sanofi Company 1,394
Large-scale testing (Phase 3)UnknownNCT04689191
What this trial is testing

A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Testing effectiveness (Phase 2)Study completedNCT00700635
What this trial is testing

Dose Comparison Study of Menactra® in US Children

Who this might be right for
MeningitisMeningococcal InfectionNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 333
Early research (Phase 1)Study completedNCT01482052
What this trial is testing

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 60
Large-scale testing (Phase 3)Study completedNCT00422292
What this trial is testing

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,664
Large-scale testing (Phase 3)Study completedNCT01580033
What this trial is testing

Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine

Who this might be right for
MeningitisInfluenza
Jiangsu Province Centers for Disease Control and Prevention 900
Testing effectiveness (Phase 2)Study completedNCT00874549
What this trial is testing

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Sanofi Pasteur, a Sanofi Company 216
Large-scale testing (Phase 3)Study completedNCT02003313
What this trial is testing

Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis
Beijing Minhai Biotechnology Co., Ltd 1,260
Large-scale testing (Phase 3)Study completedNCT01519713
What this trial is testing

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 200
Large-scale testing (Phase 3)Study completedNCT01642589
What this trial is testing

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 300
Load More Results